Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Infliximab Success Paves The Way For Adalimumab In Europe

Paper plane

Related Content

EU Biosimilar Action: New Competitors For Remicade/Herceptin, Four More Products Await CHMP OK

May 30 2018

Europe Ripe For Broader Biologic Use In Inflammatory Conditions

Oct 29 2015

Related Companies

Celltrion, Inc.

IQVIA Holdings Inc.

Novartis AG

Samsung Bioepis Co., Ltd.

Pfizer Inc.

Biogen, Inc.

AbbVie Inc.

Amgen, Inc.

Boehringer Ingelheim GmbH

Johnson & Johnson

Additional Topics

Europe Biosimilars Commercial Strategy BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window